Heated oral arguments at SCOTUS hint at Sanofi-Regeneron edge over Amgen in patent spat
WASHINGTON — Lawyers for Sanofi-Regeneron, Amgen, and the federal government took the stage at the Supreme Court on Monday, arguing a complicated patent case over the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.